LONDON, March 10 (Reuters) – GlaxoSmithKline has
strengthened its ties with Anglo-German biotech company Cellzome
by signing a second drug discovery deal worth up to 508 million
euros ($690 million).
Performance Optimization WordPress Plugins by W3 EDGE
